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bstract
bjective:  To evaluate the CT features of pathologically proven low grade serous carcinoma (LGSC) of the ovary.
ethods:  Patients with a pathologic diagnosis of LGSC and CT prior to oophorectomy were retrospectively identified. The CT scans in 14 patients
ere available and were analyzed for an adnexal mass, peritoneal mass and ascites. The adnexal mass was characterized as complex primarily
ystic, mixed cystic solid, or primarily solid. Calcification in the adnexal and peritoneal masses and nodes was noted.
esults:  Pathology revealed 6 patients had LGSC and 8 patients had a combined diagnosis of LGSC and serous borderline tumor (SBT) of the
vary. Of the 6 patients with only LGSC, 4 had primarily solid or mixed solid cystic adnexal masses and 5 had peritoneal masses. Calcification
as present in the adnexal and peritoneal masses in 4 patients, and in nodes in 2 patients. Of the 8 patients with co-existing LGSC and SBT, 7 had
omplex primarily cystic adnexal masses and 6 had peritoneal masses. Calcification was present in the adnexal and peritoneal masses in 5 patients
nd in nodes in 2 patients.
onclusion:  LGSC can appear as a solid, mixed solid cystic, or complex primarily cystic ovarian mass, and the appearance may be due to a
o-existing SBT. Calcification of the adnexal and peritoneal masses appears to be common. LGSC is a diagnostic consideration in patients with a
alcified adnexal mass and concurrent peritoneal masses or calcified nodes on CT.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
rg/licenses/by-nc-nd/4.0/).
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.  Introduction
Serous carcinomas are the most common epithelial malig-
ancy of the ovary. These were previously graded by pathologists
sing a three-tier system as low, intermediate or high grade
umors [1]. In recent years there has been a shift to a two-tier
rading system classifying tumors as either low grade or high
rade [2,3]. Low grade and high grade serous carcinomas of the
vary have differing histologic appearances, types of genetic
utations, clinical presentations, responsiveness to chemother-
py and prognosis [1,2]. Low grade serous carcinomas are less
ommon than high grade serous carcinomas. To our knowledge,
he imaging appearance of low grade serous carcinoma (LGSC)
f the ovary has not been previously described in the radiologic
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eport.
.  Methods
.1.  Patient  population
An institutional review board waiver was approved for this
etrospective study. A combined search of the radiology and
athology database was performed to identify patients with a
athologic diagnosis of low grade serous carcinoma involving
he ovary as well as cross-sectional imaging studies in PACS
ver an 8-year period. 48 patients were identified, of whom 25
ad preoperative CT prior to oophorectomy.
After review of the pathology reports, 7 patients were
xcluded either due to lack of LGSC in the ovary (n  = 5) or only
icroscopic foci of LGSC in the ovary (n  = 2) at pathology. 4
f these patients had serous borderline tumors of the ovaries
ith low grade serous carcinoma peritoneal implants (three
rticle under the CC BY-NC-ND license
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ynchronously and 1 metachronously 6 years later). 1 patient did
ot have a definitive diagnosis of low grade serous carcinoma
he patient had a borderline tumor in the ovary with implants
hat were possibly low grade serous carcinoma. 1 patient had
 borderline tumor of the ovary with a microscopic focus of
ow grade serous carcinoma. 1 patient had microscopic foci of
ow grade serous carcinoma on the surface of one ovary but
o preoperative imaging of the low grade serous carcinoma in
he contralateral ovary. Of the remaining 18 patients, 4 patients
nly had digitized film of the CT scans in PACS and were
herefore excluded from analysis.
The remaining 14 patients formed the study group. The
atients had a mean age of 53 years (range 23–76 years). The CT
as performed prior to chemotherapy in 12 of the 14 patients.
n 10 patients a single preoperative CT was available, and
as performed a median of 20 days (range 5–51 days) prior
o oophorectomy. 9 of these 10 patients had no neoadjuvant
hemotherapy.
In 4 patients, multiple CT scans were available prior to
ophorectomy. The initial scan was prior to chemotherapy in 3 of
he 4 patients and was performed a median of 174 days (range
9–295 days) prior to oophorectomy. 3 of the 4 patients each
ad 3 CT scans and 1 patient had 2 CT scans prior to oophorec-
omy. The final CT scan prior to oophorectomy was performed
 median of 30 days (range 9–49 days) before surgery. For the
 patients with multiple CT scans, the initial CT was used for
escribing the tumor findings in Tables 1 and 2 while the findings
n followup CT are noted in Table 3.
.2.  CT  technique
CT of the abdomen and pelvis was done in 13 patients, and
 patient (patient number 10) only had a pelvic CT. CT was
one with oral and intravenous contrast in 10 patients, with only
ral contrast in 3 patients (patient numbers 4, 5, 11) and with
nly intravenous contrast in 1 patient (patient number 3). In 2
atients, multiphase studies were available to assess for change
n density. 1 patient (patient number 9) had pre and post intra-
enous contrast phase images. 1 patient (patient number 14) had
ost intravenous contrast images in the renal corticomedullary
nd excretory phases.
.3.  Analysis  of  CT  images
An abdominal radiologist, with greater than 15 years of
ostfellowship experience in CT, evaluated each CT for the fol-
owing characteristics – presence of an adnexal mass, peritoneal
mplants, calcified nodes and ascites.
The adnexal masses were characterized as primarily (>75%)
ystic, mixed cystic solid, or primarily (>75%) solid. In addition
o the following CT criteria, the solid or cystic nature of the
ass was corroborated by ultrasound in 3 patients, by MRI in
 patients, by both ultrasound and MRI in 1 patient, and by
ubsequent multiphase CT in 1 patient. The presence of a cystic
r solid component in the adnexal mass was corroborated by the
ross pathologic description in 10 patients.
T
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On CT, a component of the lesion was classified as cystic
f it met one of the following criteria – attenuation <40 HU,
r if there were visible internal septations or mural nodular-
ty, or if there was absence of enhancement on a multiphase
tudy. The attenuation of the cystic component was recorded by
lacing a region of interest encompassing at least two thirds
f the component on an axial slice (region of interest ROI
ize median 764 mm2 range 52–6293 mm2). A component of
he lesion was classified as solid if it met one of the fol-
owing criteria – central calcifications, density greater than
elvic muscle, or evidence of enhancement on a multiphase
tudy.
As the bilateral adnexal masses and multiple peritoneal
asses were confluent in some cases and the omental plaque
ad variable measurements depending on the axial slice, the
argest measurement of the adnexal and peritoneal masses was
btained on an axial slice and the masses were classified as
1 cm, 1–5 cm or >5 cm in size. Calcification was noted as
resent or absent in the adnexal and peritoneal masses. The
resence of calcified abdominal, pelvic and anterior diaphrag-
atic nodes was also noted. Ascites was recorded as present or
bsent and qualitatively categorized as minimal, small, mod-
rate or large in volume. In patients who had multiple CT
tudies prior to surgical resection, change in the morphol-
gy of the primary and metastatic masses was qualitatively
ssessed.
.  Results
.1.  Pathology  results
6 patients had low grade serous carcinoma without associ-
ted serous borderline tumor while 8 patients had a combined
iagnosis of low grade serous carcinoma and serous borderline
umor. For the 6 patients with only low grade serous carcinoma
t pathology, the tumor involved both ovaries in all cases, and
as possibly peritoneal in origin in 2 patients.
For the 8 patients with a combined diagnosis of low grade
erous carcinoma (LGSC) and serous borderline tumor (SBT)
f the ovary, both tumors were present bilaterally in 3 patients.
 patients had a co-existing LGSC and SBT in one ovary and
 LGSC in the contralateral ovary. 1 patient had a co-existing
GSC and SBT in one ovary and a SBT in the contralateral
vary. 1 patient had a co-existing LGSC and SBT in one-ovary
nd tumor emboli in the hilar vessels of the contralateral ovary.
 patient with a remote history of unilateral oophorectomy for a
enign cyst had a co-existing LGSC and SBT in the remaining
ontralateral ovary.
.2.  CT  ﬁndings
Table 1 gives the CT findings in 6 patients with low grade
erous carcinoma without co-existing serous borderline tumor.
he tumors were primarily solid or mixed solid cystic in 4 of
he 6 patients (Fig. 1). 1 patient had a primarily cystic mass with
ural nodularity. 1 patient had a complex adnexal mass that was
ndeterminate for solid or cystic lesion on CT. Calcification was
H.K. Pannu / European Journal of Radiology Open 2 (2015) 39–45 41
Fig. 1. Low grade serous carcinoma without borderline tumor. Patient 7 is a
woman in her 20s. CT with intravenous contrast shows a primarily solid pelvic
mass (arrows) with scattered calcifications and small cystic regions.
Fig. 2. Low grade serous carcinoma with co-existing serous borderline tumor.
Patient 8 is a woman in her 60s. CT with intravenous contrast shows a primarily
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Fig. 3. Low grade serous carcinoma with co-existing serous borderline tumor.
Patient 5 is a woman in her 60s. CT with oral contrast shows a calcified right
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destructive stromal invasion in LGSC on histology [1]. Given theystic pelvic mass with partially calcified soft tissue component (arrow).
resent in about half of the adnexal masses (7 of 12 ovaries).
eritoneal masses were present in 5 of the 6 patients. Calcified
eritoneal masses were seen in patients with calcified adnexal
asses. 2 patients also had calcified nodes. Ascites was minimal
r small in volume in 5 patients.
Table 2 gives the CT findings in 8 patients with low grade
erous carcinoma present in conjunction with serous borderline
umor. The tumors were complex primarily cystic lesions in 7 of
he 8 patients, 4 of whom had co-existing soft tissue nodules, and
 of whom had septations (Fig. 2). 1 patient had a solid adnexal
ass (Fig. 3). Calcification was present in half of the adnexal
asses (7 of 14 ovaries). Peritoneal masses were present in 6 of
he 8 patients. Calcified peritoneal masses were seen in patients
ith calcified and noncalcified adnexal masses. 2 patients also
ad calcified nodes. In the 3 patients with differing pathology
etween the right and left ovaries, i.e. co-existing LGSC and
BT in one ovary and a LGSC or SBT in the contralateral ovary,
here was no visible difference in morphology on CT. Ascites
m
adnexal mass (arrows) abutting uterus (u). Calcified right iliac node (arrowhead)
s also present. Oral contrast is in small bowel loops in the anterior pelvis.
as absent in 5 patients and was minimal or small in volume in
 patients.
Table 3 gives the CT findings in 4 patients who had multiple
T scans prior to oophorectomy. All patients received neoad-
uvant chemotherapy. Increased calcification of the adnexal,
eritoneal and nodal masses was noted on the followup study
Fig. 4). There was no development of significant ascites.
.  Discussion
Serous carcinoma comprises 85% of epithelial ovarian malig-
ancies [1]. The majority are high grade serous carcinomas
HGSC) while an estimated 3–10% are low grade serous car-
inomas (LGSC) [1,2,4]. Significant clinical, pathologic, and
athogenesis differences have been described between LGSC
nd HGSC. Patients with LGSC tend to be younger than patients
ith HGSC and to have a better survival. In one study, mean age
nd mean survival were 55 years and 99 months for LGSC and
3 years and 57 months for HGSC [5]. At pathology, LGSC and
GSC differ in the degree of nuclear atypia and mitotic rate
ith less atypia and fewer mitoses in LGSC [4]. On a genetic
evel, KRAS or BRAF genetic mutations are seen in LGSC while
P53 mutations are more common in HGSC [6]. LGSC is theo-
ized to arise more slowly from precursor lesions while HGSC
evelops more rapidly possibly arising from tubal intraepithelial
arcinoma [6]. The pathogenesis of LGSC is believed to occur
tep-wise from cystadenoma to atypical proliferative serous
umor (APST) to noninvasive micropapillary serous borderline
umor (SBT) to low grade serous carcinoma (LGSC) [6].
This development of LGSC from serous borderline tumors
ikely accounts for the association between the two entities in
he literature as well as in our study [3]. Approximately 60%
f LGSC are reported to be associated with a SBT and patients
ith advanced stage SBT often recur as LGSC [1]. The distinc-
ion between LGSC and SBT is made based on the presence oficroscopic nature of this distinction, distinguishing the LGSC
nd SBT components in ovaries with both lesions on a gross scale
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Table 1
Low grade serous carcinoma without borderline tumor.
Pt Adnexal mass Peritoneal implants
Calcification/mass size
Calcified
nodes
Ascites
Right Left Pelvic Abdominal
1 Solid 1–5 cm mass with
calcification
Solid 1–5 cm mass with
calcification
Calcified > 5 cm Calcified > 5 cm Diaph 1 cmˆ
Abd 1–2 cmˆ
Ing > 2 cm
Minimal
2 Solid 1–5 cm mass without
calcification
Mass > 75% solid with
calcification
Mass > 5 cm
Calcified 1–5 cm Calcified > 5 cm Diaph < 1 cmˆ
Iliac > 2 cm
Ing < 1 cmˆ
Small
3 Mass > 75% cystic 10 HU
with mural nodularity without
calcification
Mass > 5 cm
Mass > 75% cystic 19 HU
without calcification
Mass 1–5 cm
Noncalcified < 1 cm Noncalcified
1–5 cm
None* Minimal
7 Solid > 5 cm mass with
calcification
Mixed solid cystic > 5 cm
mass with calcification
Calcified > 5 cm Noncalcified
1–5 cm
None Minimal
9 Mixed solid cystic > 5 cm
mass with calcification
Mixed solid cystic > 5 cm
mass with calcification
Calcified 1–5 cm Calcified > 5 cm None* Minimal
10 Noncalcified ovary 1–5 cm Mixed density cystic vs.
solid > 5 cm mass with
punctate calcification
Noneˆ No abdominal
CT available
Noneˆ None
All patients had bilateral ovarian involvement with low grade serous carcinoma.
I. Additional imaging findings:
a. In patient 9 – attenuation on precontrast/post IV contrast images – right ovary cystic part 16 HU/23 HU, right ovary solid part 45 HU/77 HU, left ovary cystic
part 15 HU/23 HU, left ovary solid part 49 HU/76 HU.
b. In patient 10 – left adnexal mass had a 38 HU locule and a 60 HU locule on CT & was a mixed signal intensity cystic mass without internal enhancement on
MRI.
II. CT and pathologic correlation:
a. CT and pathology were concordant for the presence or absence of peritoneal or nodal metastases except in cases denoted by oˆr *. ˆIndicates cases where
pathology was not available.
b. * Indicates cases where pathology showed metastatic disease. (A) in patient 9, 1 of 16 abdominal nodes resected had tumor. (B) In patient 3, 1 of 1 pelvic
I bd: ab
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II. Abbreviations: Pt: patient number; Diaph: anterior diaphragmatic nodes; A
n CT will likely be challenging. Radiologic histologic correla-
ion was not possible in this retrospective study. On MRI, SBT
ave a range of appearances which include unilocular or multi-
ocular cysts with papillary projections, septated cystic lesions,
r mixed solid cystic masses with enhancing soft tissue com-
onents [7–9]. High signal intensity is reported in the cyst fluid
n T1 weighted images in some cases suggesting hemorrhage
r proteinaceous material. This likely accounts for the cyst fluid
t
p
w
ig. 4. Low grade serous carcinoma on serial CT. Patient 2 is a woman in her 60s. (a) 
ass (arrows). Oral contrast is in small bowel loops (s). A calcified left psoas mass (*
esenteric mass (arrows). Oral contrast is in small bowel loops (s). The calcified leftdominal nodes; Ing: inguinal nodes.
eing higher than water density on CT in several cases in our
tudy. The mixed solid cystic mass appearance of borderline
umors is similar to that of ovarian malignancy.
Psammoma bodies are calcified extracellular bodies that can
ccur in serous ovarian and peritoneal neoplasms as well as in
hyroid masses [10]. They are common in LGSC. In a series of 53
atients, 29 (56%) patients had psammoma bodies at pathology
ithout meeting the definition of psammomacarcinoma [2,11].
Initial CT with oral and intravenous contrast shows a calcified solid mesenteric
) is partially imaged. (b) CT 4 months later shows increased calcification of the
 psoas mass (*) is again imaged.
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Table 2
Low grade serous carcinoma with borderline tumor.
Pt Adnexal mass
CT finding/pathology
Peritoneal implants
Calcification/mass size
Calcified
nodes
Ascites
Right Left Pelvic Abdominal
4 Mass > 75% cystic
36 HU with nodular
calcification
Mass > 5 cm
LGSC&SBT Mass > 75% cystic
32 HU with nodular
calcification
Mass > 5 cm
LGSC Calcified 1–5 cm Calcified > 5 cm Abd < 1 cm  ˆ None
5 Mass > 75% solid
with calcification
Mass > 5 cm
LGSC&SBT Noncalcified ovary
1–5 cm
LGS* None* Noncalcified < 1 cm
except for punctate
calcification
Abd < 1 cmˆ
Iliac 1–2 cmˆ
None
6 Remote
oophorectomy
Benign Mass > 75% cystic
33 HU with soft tissue
nodularity & punctate
calcification
Mass > 5 cm
LGSC&SBT Calcified < 1 cm Calcified 1–5 cm None None
8 Mass > 75% cystic
38 HU with soft tissue
nodularity &
calcification
Mass > 5 cm
LGSC&SBT Mass > 75% cystic
23 HU with soft tissue
nodularity &
calcification
Mass > 5 cm
LGSC&SBT Calcified 1–5 cm None* None None
11 Mass > 75% cystic
0 HU with septations
& calcification
Mass 1–5 cm
LGSC&SBT Mass > 75% cystic
24 HU with septations
& calcification
Mass > 5 cm
LGSC Calcified 1–5 cm Calcified < 1 cm None Small
12 Mass > 75% cystic
34 HU with soft tissue
nodularity & without
calcification
Mass > 5 cm
LGSC&SBT Mixed solid cystic
(30 HU) mass without
calcification
Mass 1–5 cm
LGSC&SBT None None None None
13 Mass > 75% cystic
48 HU with septations
without calcification
Mass > 5 cm
LGSC&SBT Mass > 75% cystic
44 HU with septations
without calcification
Mass > 5 cm
SBT None None None* Minimal
14 Mass > 75% cystic
47 HU with septations
without enhancement
without calcification
Mass > 5 cm
LGSC&SBT Mass > 75% cystic
49 HU with septations
without enhancement
without calcification
Mass > 5 cm
LGSC&SBT Calcified < 1 cm None* None* Small
Patients had ovarian low grade serous carcinoma (LGSC), serous borderline tumor (SBT), or both.
I. Additional imaging findings:
a. In patient 14 – attenuation on renal corticomedullary phase/early excretory phase/more delayed excretory phase images – right ovary 37 HU/47 HU/49 HU,
left ovary 43 HU/49 HU/48 HU.
II. CT and pathologic correlation:
a. CT and pathology were concordant for the presence or absence of peritoneal or nodal metastases except in cases noted by oˆr *. ˆIndicates cases where
pathology was not available.
b. * Indicates cases where pathology showed metastatic disease. (A) In patient 5, there were tumor emboli in the hilar vessels of the left ovary, the ovary was
otherwise unremarkable at pathology. Tumor implants were also noted on the uterus. (B) In patient 8, an omental fragment had microscopic tumor without
grossly visible mass. (C) In patient 13, 1 out of 2 abdominal nodes resected had tumor while the pelvic nodes were benign. (D) In patient 14, the omentum
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shad tumor, 1 out of 3 right iliac nodes had tumor, and the remaining pe
II. Abbreviations: Pt: patient number; Diaph: anterior diaphragmatic nodes; A
n order for a serous neoplasm to be considered a psammomacar-
inoma, at least 75% of the papillae have to contain psammoma
odies in addition to other pathologic criteria [11,12]. There are
 few clinical case reports of psammomacarcinomas and cal-
ification in serous neoplasms has also been reported on CT
10,13–15].This appearance of a calcified solid or complex cystic mass
laces LGSC in the differential for adnexal masses that can
alcify. These include exophytic uterine or broad ligament
H
m
fiodal stations were benign.
dominal nodes; Ing: inguinal nodes.
broids and ovarian lesions such as Brenner tumors, fibromas
nd dermoids. Fibroids can be variably calcified with popcorn,
eripheral or dense calcification. Feeding vessels from the uterus
an help show the uterine origin of exophytic fibroids. Brenner
umors can be complex cystic or solid masses and have exten-
ive calcifications similar to the LGSC tumors in our study [16].
owever, Brenner tumors are usually benign lacking distant
etastases [8,16]. Fibromas have focal or diffuse dense calci-
cation in a minority of cases (<10%) and calcification is rare
44 H.K. Pannu / European Journal of Radiology Open 2 (2015) 39–45
Table 3
Low grade serous carcinoma on serial CT.
Pt days Adnexal mass Peritoneal implants
Calcification/mass size
Calcified nodes Ascites
Right Left Pelvic Abdominal
1 t-165 Calcified 1–5 cm solid
mass
Calcified 1–5 cm solid
mass
Calcified > 5 cm Calcified > 5 cm Diaph 1 cm
Abd 1–2 cm
Ing > 2 cm
Minimal
t-32 Increased calcification
1–5 cm mass
Increased calcification
1–5 cm mass
Increased calcifi-
cation > 5 cm
Increased calcifi-
cation > 5 cm
Increased calcification Minimal
2 t-183 Noncalcified 1–5 cm
solid mass
Calcified > 5 cm
primarily solid mass
Calcified 1–5 cm Calcified > 5 cm Diaph < 1 cm
Iliac > 2 cm
Ing < 1 cm
Small
t-28 Surface calcification
1–5 cm mass
Increased
calcification > 5 cm
mass
Increased calcifi-
cation > 5 cm
Increased calcifi-
cation > 5 cm
Increased
calcification + new
Abd 1–2 cm
Minimal
3 t-89 Noncalcified 5.2 cm
cystic mass
Noncalcified 3.9 cm
cystic mass
Noncalcified < 1 cm Noncalcified
1–5 cm
None Minimal
t-9 Minimal calcification
4.3 cm cystic mass
Minimal calcification
2 cm cystic mass
Calcified < 1 cm Noncalcified
1–5 cm
None None
4 t-295 Calcified 8.8 cm
cystic mass
Calcified 7.0 cm
cystic mass
Calcified 1–5 cm Calcified > 5 cm Abd < 1 cm None
t-49 Increased calcification
9.1 cm cystic mass
Increased calcification
7.7 cm cystic mass
Increased
calcification
1–5 cm
Increased calcifi-
cation > 5 cm
Increased calcification None
Findings in patients with serial CT scans prior to oophorectomy. All patients received neoadjuvant chemotherapy. Change noted on subsequent scan. T-# = number
o
A bdom
i
a
i
N
i
e
a
p
i
n
a
i
a
1
p
s
c
s
C
i
g
5
s
m
b
o
c
c
C
Rf days CT done prior to oophorectomy.
bbreviations: Pt: patient number; Diaph: anterior diaphragmatic nodes; Abd: a
n thecomas [8,17–19]. The presence of fat readily categorizes
 calcified adnexal mass as a dermoid.
Features that can distinguish LGSC from benign entities
nclude the presence of nodal calcification or peritoneal masses.
odal calcification was seen in 4 of the 14 patients with LGSC
n our study. In the absence of an infectious or inflammatory
tiology, the presence of nodal calcification in a patient with
 calcified adnexal mass raises the concern for a serous neo-
lasm [15]. Peritoneal implants are also seen in LGSC but not
n patients with benign adnexal masses. However, ascites does
ot appear to be a helpful distinguishing feature. Ascites was not
 prominent finding in the patients with LGSC in our study, even
n those with peritoneal masses and serial CT scans. Ascites is
lso uncommon in fibromas, with Meigs syndrome occurring in
% of cases [18].
In the few patients with multiple CT scans, the adnexal and
eritoneal masses showed increased calcification over time pos-
ibly due to the natural course of the disease and/or secondary to
hemotherapy effect. LGSC are considered to be fairly chemore-
istant [1,20].
Although the number of patients in this study is small, the
T findings of this uncommon tumor were evaluated in patients
n whom the diagnosis of LGSC had been made by specialty
ynecologic pathologists from a single institution.
.  ConclusionLow grade serous carcinoma of the ovary can appear as a
olid, mixed solid cystic, or complex primarily cystic adnexal
ass, and the appearance may be due to a co-existing serousinal nodes; Ing: inguinal nodes.
orderline tumor. Calcification of the adnexal mass and perit-
neal metastases appears to be common. LGSC is a diagnostic
onsideration in patients with a calcified adnexal mass and con-
urrent peritoneal masses or calcified nodes on CT.
onﬂict  of  interest
The author declare that no conflict of interest.
eferences
[1] Romero I, Sun CC, Wong KK, Bast Jr RC, Gershenson DM. Low-grade
serous carcinoma: new concepts and emerging therapies. Gynecol Oncol
2013;130(September (3)):660–6.
[2] Diaz-Padilla I, Malpica AL, Minig L, Chiva LM, Gershenson DM,
Gonzalez-Martin A. Ovarian low-grade serous carcinoma: a comprehensive
update. Gynecol Oncol 2012;126(August (2)):279–85.
[3] Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson
DM, et al. Grading ovarian serous carcinoma using a two-tier system. Am
J Surg Pathol 2004;28(April (4)):496–504.
[4] Malpica A. Grading of ovarian cancer: a histotype-specific approach. Int J
Gynecol Pathol 2008;27(April (2)):175–81.
[5] Plaxe SC. Epidemiology of low-grade serous ovarian cancer. Am J Obstet
Gynecol 2008;198(April (4)), 459.e1-8; discussion 459.e8-9.
[6] Vang R, Shih IeM, Kurman RJ. Ovarian low-grade and high-grade serous
carcinoma: pathogenesis, clinicopathologic and molecular biologic fea-
tures, and diagnostic problems. Adv Anat Pathol 2009;16(September
(5)):267–82.
[7] Bent CL, Sahdev A, Rockall AG, Singh N, Sohaib SA, Reznek RH. MRI
appearances of borderline ovarian tumours. Clin Radiol 2009;64(April
(4)):430–8.
[8] Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging
of ovarian tumors with emphasis on differential diagnosis. Radiographics
2002;22(November–December (6)):1305–25.
l of Ra
[
[
[
[
[
[
[
[
[
[H.K. Pannu / European Journa
[9] Van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Borderline ovar-
ian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol
1998;28(September (2)):136–42.
10] Giordano G, Gnetti L, Milione M, Piccolo D, Soliani P. Serous psammocar-
cinoma of the ovary: a case report and review of literature. Gynecol Oncol
2005;96(January (1)):259–62.
11] Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershen-
son DM. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol
2011;121(June (3)):482–6.
12] Gilks CB, Bell DA, Scully RE. Serous psammocarcinoma of the ovary and
peritoneum. Int J Gynecol Pathol 1990;9(2):110–21.
13] Akbulut M, Kelten C, Bir F, Soysal ME, Duzcan SE. Primary periton-
eal serous psammocarcinoma with recurrent disease and metastasis: a
case report and review of the literature. Gynecol Oncol 2007;105(April
(1)):248–51.
14] Hiromura T, Tanaka YO, Nishioka T, Tomita K. Serous psammocar-
cinoma of the ovary: CT and MR findings. J Comput Assist Tomogr
2007;31(May–June 3):490–2.
[diology Open 2 (2015) 39–45 45
15] Agarwal A, Yeh BM, Breiman RS, Qayyum A, Coakley FV. Peritoneal cal-
cification: causes and distinguishing features on CT. AJR Am J Roentgenol
2004;182(February (2)):441–5.
16] Moon WJ, Koh BH, Kim SK, Kim YS, Rhim HC, Cho OK, et al. Bren-
ner tumor of the ovary: CT and MR findings. J Comput Assist Tomogr
2000;24(January–February (1)):72–6.
17] Shambhogue AKP, Shambhogue DKP, Prasad SK, Surabhi VR, Fasih N,
Menias CO. Clinical syndromes associated with ovarian neoplasms: a com-
prehensive review. Radiographics 2010;30:903–19.
18] Sex cord-stromal and steroid cell tumors.Clement PB, Young RH, editors.
Atlas of gynecologic surgical pathology. Philadelphia, PA: Elsevier Inc.;
2008. p. 386–414 [Chapter 16].
19] Outwater EK, Wagner BJ, Mannion C, McLarney JK, Kim B. Sex
cord-stromal and steroid cell tumors of the ovary. Radiographics
1998;18:1523–46.
20] Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A,
et al. Clinical behavior of stage II–IV low-grade serous carcinoma of the
ovary. Obstet Gynecol 2006 Aug;108(2):361–8.
